Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease

Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes

NCT02140671 ·Status: UNKNOWN

Biomarkers in Exhaled Breath From Asthmatic Patients

NCT00635271 ·Status: TERMINATED

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00252863 ·Status: COMPLETED ·Phase: PHASE3

A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients

NCT00331292 ·Status: TERMINATED

Study In Asthma Control

NCT00273026 ·Status: TERMINATED ·Phase: PHASE4

Does Shared Decision-Making Improve Asthma Outcomes?

NCT00149526 ·Status: COMPLETED ·Phase: NA

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

NCT00189787 ·Status: COMPLETED ·Phase: PHASE2

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

NCT00583986 ·Status: COMPLETED ·Phase: PHASE3

Real-world Effectiveness of Combination Therapy in Asthma

NCT01141465 ·Status: COMPLETED

Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home

NCT01783132 ·Status: TERMINATED ·Phase: NA

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma

NCT02567708 ·Status: COMPLETED ·Phase: PHASE2

Mediator Release During Exercise-induced Bronchoconstriction

NCT03524053 ·Status: UNKNOWN ·Phase: NA

Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia

NCT01114906 ·Status: COMPLETED

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

NCT00096616 ·Status: COMPLETED ·Phase: PHASE2

Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects

NCT00331058 ·Status: TERMINATED ·Phase: PHASE1

Study in Adult Patients With Moderate to Severe Asthma

NCT04886999 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients

NCT01577082 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

NCT00163358 ·Status: COMPLETED ·Phase: PHASE3

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

NCT02537691 ·Status: COMPLETED ·Phase: PHASE4

Inhaler Adherence in Severe Unstable Asthma

NCT02307669 ·Status: UNKNOWN ·Phase: NA

Device Mixing in Asthma, a General Practice Research Database Study

NCT01313585 ·Status: COMPLETED

Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database

NCT05136547 ·Status: COMPLETED

Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy

NCT03629782 ·Status: COMPLETED

Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

NCT07301736 ·Status: RECRUITING ·Phase: PHASE2

A Study of Inhaler Use in the Community

NCT02552472 ·Status: COMPLETED